Delivery Order SPE2DB22D3004-SPE2DB25FRY81
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,064.07 to AmerisourceBergen Drug Corp for the supply of Savella 50 mg tablets (60-count units) on August 4, 2025, with completion expected by August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be delivered to the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,237.86 to AmerisourceBergen Drug Corp for Savella 100 mg tablets (60-count units) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Savella (milnacipran) is a serotonin-norepinephrine reuptake inhibitor indicated for fibromyalgia...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Savella 25 mg tablets (60-count packaging) with a ceiling value of $4,676.17. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 14, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Savella 50 mg tablets (60-count units) with a contract value of $26,478.90. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Savella (milnacipran) 100 mg tablets in a 60-count quantity. This is a firm fixed-price, non-set-aside contract with a ceiling value of $3,669.15 and an ultimate completion date of July 29, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Savella 100 mg tablets (60-count units) with a ceiling value of $4,750.50. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Savella (milnacipran) is a serotonin-norepinephrine reuptake inhibitor...
- The Defense Logistics Agency awarded a $2,111.57 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Savella 100 mg, a neurological medication used in pain management. This competitive contract, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Savella 100 mg tablets. The $2,623.36 firm-fixed-price delivery order is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Savella 50 mg tablets, a medication used to treat fibromyalgia. The contract has a ceiling value of $2,733.67 and a completion date of June 18, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $6,513.98 firm-fixed price delivery order is for the supply of Savella 50 mg tablets. This contract is not set aside for any specific business type. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. This IDC serves as the...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRY81Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,727.50 to AmerisourceBergen Drug Corp for the supply of Savella 100 mg tablets (60-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceuticals and medical supplies to military healthcare programs worldwide. Savella (milnacipran) is a centrally acting analgesic used primarily for fibromyalgia pain management. As a major federal pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's demonstrated capability to meet federal procurement requirements through open competition, combined with its significant prime vendor relationships with DLA, positions it as a key supplier of pharmaceutical commodities supporting military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 8/12/25 |